Marburg, Germany

Horst Schwinn


Average Co-Inventor Count = 2.7

ph-index = 10

Forward Citations = 341(Granted Patents)


Location History:

  • Marbach-Michelbach, DE (1976)
  • Marbach, Marburg an der Lahn, DE (1976)
  • Marburg-Michelbach, DE (1977)
  • Marburg/Lahn, DE (1983)
  • Marburg an der Lahn, DE (1978 - 1987)
  • Mainz, DE (1999 - 2000)
  • Marburg, DE (1983 - 2003)

Company Filing History:


Years Active: 1976-2003

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Horst Schwinn

Introduction

Horst Schwinn, a notable inventor based in Marburg, Germany, has made significant contributions to the field of medical innovations. With a total of 16 patents, his work primarily focuses on methods that enhance the purification and inactivation of viruses in biological materials.

Latest Patents

Among his latest inventions is a "Method for the inactivation of non-lipid-coated viruses." This groundbreaking method targets the inactivation of viruses that lack lipid coats in protein-containing compositions derived from blood or similar natural sources. By treating these sources with an effective amount of dialkyl or trialkyl phosphates, and possibly surfactants, at elevated temperatures ranging from 55°C to 67°C for durations of five to thirty hours, Schwinn has advanced the safety and efficacy of biological preparations.

Another significant patent from Schwinn is the "Method for the affinity-chromatographic purification of factor VIII," highlighting his expertise in hemophilia treatment advancements through efficient means of purifying essential clotting factors.

Career Highlights

Horst Schwinn has a distinguished career, having worked with leading organizations in the pharmaceutical industry, including Behringwerke Aktiengesellschaft and Octapharma AG. His contributions in these capacities have supported advancements in biotherapeutics and medical technologies.

Collaborations

During his career, Schwinn has collaborated with esteemed colleagues such as Norbert Heimburger and Gerhardt Kumpe. These partnerships have facilitated innovative solutions in their respective fields, emphasizing the synergy that collaborative efforts can produce in medical science.

Conclusion

Horst Schwinn's dedication to innovation has not only resulted in multiple patents but has also significantly impacted the future of medical research and therapies. His pioneering methods for virus inactivation and purification of crucial factors underscore his commitment to advancing healthcare and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…